SCHEMBL10054802

SCHEMBL10054802

Cc1ccc(C(=O)Nc2ccc(C)c(NC(=O)/C=C/c3cccnc3)c2)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 13/20 0.63
NPC1 O15118 2/20 0.62
KMT2A Q03164 3/20 0.56
LMNA P02545 2/20 0.56
MAPT P10636 2/20 0.56
MEN1 O00255 2/20 0.56
GALR2 O43603 1/20 0.56
HPGD P15428 1/20 0.56
RECQL P46063 1/20 0.56
HDAC1 Q13547 2/20 0.53
HDAC3 O15379 1/20 0.52
ABL1 P00519 1/20 0.52
PDGFRB P09619 1/20 0.52
BCR P11274 1/20 0.52
KDR P35968 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679937 1.00 NAMPT (0.63) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL10078412 0.91 NAMPT (0.57) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL2679216 0.91 NAMPT (0.57) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL2679172 0.89 NAMPT (0.58) NAMPTKMT2ALMNAMAPTMEN1
SCHEMBL10054799 0.89 NAMPT (0.58) NAMPTKMT2ALMNAMAPTMEN1
SCHEMBL10054898 0.89 NPC1 (0.51) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL2678902 0.89 L3MBTL1 (0.58) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL10077684 0.89 L3MBTL1 (0.58) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL10054900 0.89 HDAC1 (0.56) NAMPTNPC1KMT2ALMNAMAPT
SCHEMBL10054800 0.87 NAMPT (0.64) NAMPTKMT2ALMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426446-B2 Acrylamide derivative and use thereof in manufacture of medicament BEIJING SHIQIAO BIOPHARM CO. LTD. (CN) 2013-04-23 US disclosed
US-8426446-B2 Acrylamide derivative and use thereof in manufacture of medicament BEIJING SHIQIAO BIOPHARM CO. LTD. (CN) 2013-04-23 US disclosed
US-20120116075-A1 Acrylamide Derivative And Use Thereof In Manufacture Of Medicament BEIJING JIASHILIANBO PHARM SCI & TECH CO. LTD 2012-05-10 US disclosed
US-20120116075-A1 Acrylamide Derivative And Use Thereof In Manufacture Of Medicament BEIJING JIASHILIANBO PHARM SCI & TECH CO. LTD 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120116075-A1 Acrylamide Derivative And Use Thereof In Manufacture Of Medicament ABL1, ABL2, BCR NAMPT 3700/4885NPC1 4708/4885KMT2A 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.